Aarti Pharmalabs Limited (NSE:AARTIPHARM)

India · Delayed Price · Currency is INR

691.80

+33.30 (5.06%)

Jun 19, 2026, 3:30 PM IST

-21.46% (1Y)

Market Cap	62.72B -24.0%
Revenue (ttm)	18.19B -14.0%
Net Income	1.75B -35.9%
EPS	19.25 -35.9%
Shares Out	90.66M
PE Ratio	35.94
Forward PE	38.87
Dividend	3.50 (0.51%)
Ex-Dividend Date	Feb 16, 2026

Volume	675,118
Open	657.40
Previous Close	658.50
Day's Range	653.00 - 706.00
52-Week Range	585.00 - 971.00
Beta	0.23
Analysts	Hold
Price Target	740.00 (+6.97%)
Earnings Date	May 25, 2026

About Aarti Pharmalabs

Aarti Pharmalabs Limited, together with its subsidiaries, manufactures and sells active pharmaceutical ingredients, pharmaceutical intermediates, and xanthine derivatives in India and internationally. The company offers active pharmaceutical ingredients for various therapeutic areas, such as cardiovascular, anti-asthmatic, anti-cancer, anti-coagulant, anti-diabetic, arthritis, central nervous system agent, skincare, overactive bladder, calcimimetic, decongestant, anti-thalassaemic, analgesic, and ophthalmologic medications. It also provides con... [Read more]

Industry Drug Manufacturers - Specialty & Generic

Sector Healthcare

Founded 2019

Employees 2,162

Stock Exchange National Stock Exchange of India

Ticker Symbol AARTIPHARM

Full Company Profile

Financial Performance

In fiscal year 2026, Aarti Pharmalabs's revenue was 18.19 billion, a decrease of -13.98% compared to the previous year's 21.15 billion. Earnings were 1.75 billion, a decrease of -35.86%.

Financial Statements